Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niklas Mattsson

Showing results (151-160 of 395) with videos related to

Pageof 40
Sort By:
Journal of Alzheimer'S Disease : JAD|August 14, 2012
Mass spectrometric characterization of amyloid-β species in the 7PA2 cell model of Alzheimer's diseaseErik Portelius, Maria Olsson, Gunnar Brinkmalm, et al.
Alzheimer'S Research & Therapy|October 12, 2024
Biological mechanisms of resilience to tau pathology in Alzheimer's diseaseAnna L Svenningsson, Diana I Bocancea, Erik Stomrud, et al.
Alzheimer'S Research & Therapy|July 5, 2024
Predicting progression from subjective cognitive decline to mild cognitive impairment or dementia based on brain atrophy patternsOndrej Lerch, Daniel Ferreira, Erik Stomrud, et al.
Nature Aging|September 18, 2023
DOPA decarboxylase is an emerging biomarker for Parkinsonian disorders including preclinical Lewy body diseaseJoana B Pereira, Atul Kumar, Sara Hall, et al.
Annals of Clinical and Translational Neurology|April 5, 2016
CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer diseaseShorena Janelidze, Henrik Zetterberg, Niklas Mattsson, et al.
JAMA Neurology|November 9, 2020
Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer DiseaseShorena Janelidze, David Berron, Ruben Smith, et al.
Alzheimer'S Research & Therapy|March 20, 2024
Comparing a pre-defined versus deep learning approach for extracting brain atrophy patterns to predict cognitive decline due to Alzheimer's disease in patients with mild cognitive symptomsIda Arvidsson, Olof Strandberg, Sebastian Palmqvist, et al.
Pain Reports|January 31, 2022
Central nervous system monoaminergic activity in hip osteoarthritis patients with disabling pain: associations with pain severity and central sensitizationMartin F Bjurström, Kaj Blennow, Henrik Zetterberg, et al.
Journal of Alzheimer'S Disease : JAD|September 24, 2023
Effects of Brain Pathologies on Spatiotemporal Gait Parameters in Patients with Mild Cognitive ImpairmentMagnus Lindh-Rengifo, Stina B Jonasson, Susann Ullén, et al.
Brain : a Journal of Neurology|September 17, 2015
Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's diseaseErik Portelius, Henrik Zetterberg, Tobias Skillbäck, et al.
Pageof 40

Showing results (151-160 of 395) with videos related to

Sort By:
Pageof 40
Journal of Alzheimer'S Disease : JAD|August 14, 2012
Mass spectrometric characterization of amyloid-β species in the 7PA2 cell model of Alzheimer's diseaseErik Portelius, Maria Olsson, Gunnar Brinkmalm, et al.
Alzheimer'S Research & Therapy|October 12, 2024
Biological mechanisms of resilience to tau pathology in Alzheimer's diseaseAnna L Svenningsson, Diana I Bocancea, Erik Stomrud, et al.
Alzheimer'S Research & Therapy|July 5, 2024
Predicting progression from subjective cognitive decline to mild cognitive impairment or dementia based on brain atrophy patternsOndrej Lerch, Daniel Ferreira, Erik Stomrud, et al.
Nature Aging|September 18, 2023
DOPA decarboxylase is an emerging biomarker for Parkinsonian disorders including preclinical Lewy body diseaseJoana B Pereira, Atul Kumar, Sara Hall, et al.
Annals of Clinical and Translational Neurology|April 5, 2016
CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer diseaseShorena Janelidze, Henrik Zetterberg, Niklas Mattsson, et al.
JAMA Neurology|November 9, 2020
Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer DiseaseShorena Janelidze, David Berron, Ruben Smith, et al.
Alzheimer'S Research & Therapy|March 20, 2024
Comparing a pre-defined versus deep learning approach for extracting brain atrophy patterns to predict cognitive decline due to Alzheimer's disease in patients with mild cognitive symptomsIda Arvidsson, Olof Strandberg, Sebastian Palmqvist, et al.
Pain Reports|January 31, 2022
Central nervous system monoaminergic activity in hip osteoarthritis patients with disabling pain: associations with pain severity and central sensitizationMartin F Bjurström, Kaj Blennow, Henrik Zetterberg, et al.
Journal of Alzheimer'S Disease : JAD|September 24, 2023
Effects of Brain Pathologies on Spatiotemporal Gait Parameters in Patients with Mild Cognitive ImpairmentMagnus Lindh-Rengifo, Stina B Jonasson, Susann Ullén, et al.
Brain : a Journal of Neurology|September 17, 2015
Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's diseaseErik Portelius, Henrik Zetterberg, Tobias Skillbäck, et al.
Pageof 40